RedHill Biopharma (NASDAQ:RDHL) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research report released on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. RedHill Biopharma Stock Performance Shares of NASDAQ RDHL opened at $0.36 on Friday. RedHill Biopharma has a fifty-two week low of $0.26 and a […]
Riverview Bancorp (NASDAQ:RVSB) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Riverview Bancorp (NASDAQ:RVSB – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the savings and loans company’s stock. Riverview Bancorp Price Performance Shares of RVSB opened at $4.03 on Friday. The stock has a market capitalization of $85.07 million, a P/E […]
PACCAR (NASDAQ:PCAR) Research Coverage Started at Raymond James
Raymond James started coverage on shares of PACCAR (NASDAQ:PCAR – Free Report) in a report issued on Friday, MarketBeat.com reports. The firm issued a market perform rating on the stock. A number of other brokerages have also recently issued reports on PCAR. Truist Financial reiterated a hold rating and set a $121.00 price objective (up […]
Ohio Valley Banc (NASDAQ:OVBC) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Ohio Valley Banc (NASDAQ:OVBC – Free Report) in a research note published on Thursday. The firm issued a hold rating on the bank’s stock. Ohio Valley Banc Trading Up 1.3 % NASDAQ OVBC opened at $20.00 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio […]
Hibbett (NASDAQ:HIBB) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Hibbett (NASDAQ:HIBB – Free Report) in a research report report published on Friday morning. The firm issued a hold rating on the stock. Other equities analysts also recently issued reports about the stock. Monness Crespi & Hardt reaffirmed a neutral rating on shares of Hibbett in a research note […]
GigaMedia (NASDAQ:GIGM) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of GigaMedia (NASDAQ:GIGM – Free Report) in a report published on Thursday. The brokerage issued a sell rating on the technology company’s stock. GigaMedia Price Performance GigaMedia stock opened at $1.30 on Thursday. GigaMedia has a 52-week low of $1.23 and a 52-week high of $1.56. The stock has a […]
Oncternal Therapeutics (NASDAQ:ONCT) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note released on Friday. The firm issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and set a $19.00 price objective on shares of Oncternal Therapeutics in a research note on Friday, May 31st. Get […]
Leap Therapeutics (NASDAQ:LPTX) Research Coverage Started at Rodman & Renshaw
Rodman & Renshaw began coverage on shares of Leap Therapeutics (NASDAQ:LPTX – Free Report) in a research report sent to investors on Friday, Marketbeat.com reports. The firm issued a buy rating and a $8.00 price target on the stock. LPTX has been the subject of a number of other research reports. HC Wainwright dropped their […]
SOPHiA GENETICS (NASDAQ:SOPH) Research Coverage Started at Guggenheim
Guggenheim started coverage on shares of SOPHiA GENETICS (NASDAQ:SOPH – Free Report) in a report released on Thursday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $6.00 price objective on the stock. Several other analysts have also issued reports on the stock. Royal Bank of Canada reaffirmed an outperform rating and set […]
Diamondback Energy (NASDAQ:FANG) Research Coverage Started at KeyCorp
KeyCorp started coverage on shares of Diamondback Energy (NASDAQ:FANG – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm issued an overweight rating and a $225.00 price objective on the oil and natural gas company’s stock. A number of other research analysts have also recently weighed in on […]
Nautilus Biotechnology (NASDAQ:NAUT) Research Coverage Started at Guggenheim
Guggenheim started coverage on shares of Nautilus Biotechnology (NASDAQ:NAUT – Free Report) in a research report released on Thursday, Marketbeat.com reports. The brokerage issued a buy rating and a $6.00 price objective on the stock. Separately, Jefferies Financial Group began coverage on shares of Nautilus Biotechnology in a research report on Monday, June 3rd. They […]
Siebert Financial (NASDAQ:SIEB) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Siebert Financial (NASDAQ:SIEB – Free Report) in a research note issued to investors on Thursday. The firm issued a hold rating on the financial services provider’s stock. Siebert Financial Stock Performance Shares of NASDAQ SIEB opened at $1.74 on Thursday. The firm has a 50 day moving average price […]
SeaChange International (NASDAQ:SEAC) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of SeaChange International (NASDAQ:SEAC – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the software maker’s stock. SeaChange International Price Performance SEAC opened at $6.50 on Thursday. SeaChange International has a 52 week low of $1.50 and a 52 week high […]
ACADIA Pharmaceuticals (NASDAQ:ACAD) Research Coverage Started at BMO Capital Markets
Research analysts at BMO Capital Markets began coverage on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) in a report issued on Thursday, Marketbeat reports. The brokerage set an “outperform” rating and a $31.00 price target on the biopharmaceutical company’s stock. BMO Capital Markets’ target price would suggest a potential upside of 90.77% from […]
Corbus Pharmaceuticals (NASDAQ:CRBP) Research Coverage Started at B. Riley
B. Riley started coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research note published on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $85.00 price target on the biopharmaceutical company’s stock. B. Riley also issued estimates for Corbus Pharmaceuticals’ Q2 2024 earnings at ($0.92) EPS, Q3 2024 earnings […]
PACCAR (NASDAQ:PCAR) Research Coverage Started at Citigroup
Citigroup assumed coverage on shares of PACCAR (NASDAQ:PCAR – Free Report) in a research report report published on Wednesday morning, Marketbeat reports. The firm issued a neutral rating and a $115.00 price objective on the stock. PCAR has been the topic of several other reports. Truist Financial reiterated a hold rating and set a $121.00 […]
SenesTech (NASDAQ:SNES) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research note issued to investors on Wednesday morning. The brokerage issued a sell rating on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $3.50 price objective on shares of SenesTech in a research note on Tuesday, May 14th. […]
United Maritime (NASDAQ:USEA) Research Coverage Started at Maxim Group
Maxim Group assumed coverage on shares of United Maritime (NASDAQ:USEA – Free Report) in a research note published on Wednesday morning, Benzinga reports. The brokerage issued a buy rating and a $6.00 target price on the stock. United Maritime Price Performance Shares of NASDAQ:USEA opened at 2.60 on Wednesday. The stock’s 50-day moving average price […]
JFrog (NASDAQ:FROG) Research Coverage Started at Barclays
Barclays initiated coverage on shares of JFrog (NASDAQ:FROG – Free Report) in a research note released on Wednesday morning, Marketbeat.com reports. The brokerage issued an overweight rating and a $50.00 price objective on the stock. A number of other equities research analysts also recently issued reports on the stock. KeyCorp reduced their price target on […]
Sangamo Therapeutics (NASDAQ:SGMO) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report issued on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other equities analysts have also recently weighed in on SGMO. HC Wainwright reiterated a buy rating and set a $5.00 price objective on shares of […]
last updated on 2 Jul 15:18